Skinvisible Subsidiary Kintari Has Successful Launch

Kintari Officially in Business

Las Vegas, NV - February 4, 2015 - Skinvisible Inc., (OTCQB: SKVI) through its wholly owned subsidiary Kintari International Inc., marketer of patented "Youth Renewed" skin care products, is pleased to announce the successful official launch of its network marketing company.

"We are very pleased to announce that our January 15th official launch of Kintari in the USA was very exciting for us and the new distributors that attended from across the US," said Mr. Terry Howlett, President of Kintari.

The Kintari product portfolio consists of "Youth Renewed" (YR) anti-aging products to help fight the signs of aging. The Kintari YR product line includes a rejuvenating day cream and a renewing night cream. These products have been developed using proven anti-aging ingredients with scientific evidence of their effectiveness at reducing the look of fine lines and wrinkles resulting in youthful looking skin. These potent ingredients are powered by our patented Invisicare® skin delivery technology, providing consumers with unique, effective skincare benefits which cannot be duplicated and our Kintari distributors with products that no other company can offer. Kintari products are truly one of a kind.

"New distributor sign ups and sales for the two week period ending January 30 were above expectations and the response to our products has been outstanding said Mr. Rob Barnes, Director of Sales. Based on the success of our first month, we anticipate continued growth in both new distributors and sales over the next months. This growth will be generated by new distributors from across the USA, new product launches in 2015 and the launch of Kintari Canada in the second quarter of 2015."

Skinvisible Inc., a science-based research and development company with a patented skin delivery technology called Invisicare®, the foundation to every topical prescription (Rx), over-the-counter (OTC) and cosmeceutical product developed by Skinvisible. Skinvisible continues to build its worldwide patent portfolio while seeking licensees for its prescription line of dermatology focused products, while Kintari focuses exclusively on the marketing of OTC and cosmeceutical products powered by Invisicare. Presently the company has over fifteen patents worldwide and a portfolio of over forty products ready to be licensed or introduced to the marketplace.